Childhood testicular choriocarcinoma

Summary

Childhood testicular choriocarcinoma (MONDO:0003786) is a disease. A subtype of choriocarcinoma of testis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	childhood testicular choriocarcinoma
Mondo ID	MONDO:0003786
DOID	DOID:6160
NCIT	C6544
UMLS	C1333006
MedGen	272469
GARD	0023670
Is cancer (heuristic)	no

Also known as: childhood choriocarcinoma of testis · childhood choriocarcinoma of the testis · childhood testicular choriocarcinoma · choriocarcinoma of testis of childhood · paediatric choriocarcinoma of testis · paediatric choriocarcinoma of the testis · paediatric testicular choriocarcinoma · pediatric choriocarcinoma of testis · pediatric choriocarcinoma of the testis · pediatric testicular choriocarcinoma

Disease family

This is a subtype of choriocarcinoma of testis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › trophoblastic neoplasm › testicular trophoblastic tumor › choriocarcinoma of testis › childhood testicular choriocarcinoma

Related subtypes (1): testicular monophasic choriocarcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.